newsfilter
← Latest News
Business Wire·

TNF Pharmaceuticals and Renova Health Utilize AI to Accelerate Drug Development

Machine learning technology used to identify patients for studies of muscle mass preservation during GLP-1 treatment TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical